Clinical trial • Phase III • Cardiology
Clinical trial in Chronic kidney disease
Phase III trial for Chronic kidney disease. 18 participants.
Overview
- Trial Therapeutic Area
- Cardiology
- Trial Disease
- Chronic kidney disease
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 28-01-2026
- First CTIS Authorization Date
- 25-03-2026
Trial design
Phase III trial across 1 site in Germany.
- Target Sample Size
- 18
Eligibility
Recruits 18 Vulnerable population selected: true. No further details on consent/assent or specific vulnerable groups provided..
- Vulnerable Population
- Vulnerable population selected: true. No further details on consent/assent or specific vulnerable groups provided.
Recruitment
- Planned Sample Size
- 18
- Recruitment Window Months
- 3
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 18
Germany
- Earliest CTIS Part Ii Submission Date
- 23-03-2026
- Latest Decision Or Authorization Date
- 25-03-2026
- Processing Time Days
- 2
- Number Of Sites
- 1
- Number Of Participants
- 18
Sites
- Site Name
- CRS Clinical Research Services Berlin GmbH
- Department Name
- -
- Contact Person Name
- Sybille Baumann
- Contact Person Email
- sybille.baumann@crs-group.de
Sponsor
Primary sponsor
- Full Name
- Bayer AG
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Germany
Related trials
Other published trials that may interest you.